Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

RKDA holding history

Arcadia Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RKDA overviewAll 13F holders of RKDAFull Q2 2026 holdings

Shares (Q2 2026)
2
Value
$1
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RKDA by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262$1<0.1%00.0%UnchangedHolders
Q1 20262$3<0.1%00.0%UnchangedHolders
Q4 20252$4<0.1%−606−99.7%ReducedHolders
Q3 2025608$2.11K<0.1%−179−22.7%ReducedHolders
Q2 2025787$3.39K<0.1%+179+29.4%AddedHolders
Q1 2025608$1.81K<0.1%+1+0.2%AddedHolders
Q4 2024607$3.59K<0.1%00.0%UnchangedHolders
Q3 2024607$1.66K<0.1%00.0%UnchangedHolders
Q2 2024607$1.91K<0.1%+400+193.2%AddedHolders
Q1 2024207$457<0.1%00.0%UnchangedHolders
Q4 2023207$648<0.1%00.0%UnchangedHolders
Q3 2023207$693<0.1%−6−2.8%ReducedHolders
Q2 2023213$826<0.1%−5−2.3%ReducedHolders
Q1 2023218$1.63K<0.1%−8,278−97.4%ReducedHolders
Q4 20228,496$2.30K<0.1%+26+0.3%AddedHolders
Q3 20228,470$4.00K<0.1%−2,501−22.8%ReducedHolders
Q2 202210,971$11.0K<0.1%−6,516−37.3%ReducedHolders
Q1 202217,487$24.0K<0.1%−20,731−54.2%ReducedHolders
Q4 202138,218$39.0K<0.1%+665+1.8%AddedHolders
Q3 202137,553$78.0K<0.1%−889−2.3%ReducedHolders
Q2 202138,442$114.0K<0.1%+35,172+1,075.6%AddedHolders
Q1 20213,270$9.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.